Skip to main content
Timothy Graubert, MD, Oncology, Boston, MA, Massachusetts General Hospital

TimothyAGraubertMD

Oncology Boston, MA

Hematologic Oncology

Professor of Medicine, Harvard Medical School

Dr. Graubert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Graubert's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1993 - 1997
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Internal Medicine, 1988 - 1991
  • Harvard Medical School
    Harvard Medical SchoolClass of 1988

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • MO State Medical License
    MO State Medical License 1997 - 2014
  • CT State Medical License
    CT State Medical License 1990 - 1994
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndrome
    Timothy Graubert, MD, Clinical Cancer Research, Orlando, FL, 12/8/2019

Press Mentions

  • Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDS
    Dana-Farber Receives $5 Million Gift to Create the Edward P. Evans Center for MDSSeptember 16th, 2019
  • $11.5 Million Supports Innovation in Leukemia Research
    $11.5 Million Supports Innovation in Leukemia ResearchNovember 6th, 2018
  • Expert Point of View: Robert Hromas, MD
    Expert Point of View: Robert Hromas, MDJanuary 26th, 2016
  • Join now to see all

Grant Support

  • Genomics Of Treatment -Related Acute Myelogenous Leukemia: Susceptibility FactorsNational Cancer Institute2008–2012
  • High Speed Cell Sorter CoreNational Cancer Institute2010–2011
  • Whole Genome Sequencing Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2009–2010
  • Genomics Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2005–2008
  • Core--High Speed Cell Sorter FacilityNational Cancer Institute2004–2008
  • Acquistion Of An Influx GMP Cell Sorter: Infectious DiseaseNational Center For Research Resources2005
  • Acquistion Of An Influx GMP Cell Sorter: ImmunologyNational Center For Research Resources2005
  • Acquistion Of An Influx GMP Cell Sorter: Adult Human Stem CellsNational Center For Research Resources2005
  • Acquistion Of An Influx GMP Cell Sorter.National Center For Research Resources2005
  • Genetic Targeting Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute1998–2002
  • Acquistion Of A Cytomation Moflo Cell SorterNational Center For Research Resources2001

Hospital Affiliations